4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001447028-21-000006
Options or other derivatives
- Chief Business Officer acquired 249,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
McElhaugh Michael J. · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-13 | Grant or award : show line 1 in the form Stock Options | +249,000 | 249,000 | D |
Loading xslF345X03/wf-form4_161359884797554.xml…